ArticleOncotarget2020

Reassessing the role of high dose cytarabine and mitoxantrone in relapsed/refractory acute myeloid leukemia.

Jonathan Canaani et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.